Mgenplus Co. Ltd. (032790) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.049x

Based on the latest financial reports, Mgenplus Co. Ltd. (032790) has a cash flow conversion efficiency ratio of -0.049x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.35 Billion ≈ $-912.17K USD) by net assets (₩27.60 Billion ≈ $18.70 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Mgenplus Co. Ltd. for the company's overall valuation and market capitalisation.

Mgenplus Co. Ltd. - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Mgenplus Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mgenplus Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mgenplus Co. Ltd. ranked by their cash flow conversion efficiency. Explore Mgenplus Co. Ltd. (032790) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Accent Resources NL AU:ACS	-0.036x
AGMO KLSE:0258	0.051x
Vyne Therapeutics Inc NASDAQ:VYNE	-0.136x
Duckshin Housing Co. Ltd KQ:090410	-0.080x
DAP Corporation KQ:066900	-0.045x
Eagon Ind KO:008250	0.033x
Microfriend Inc KQ:147760	-0.061x
FNC Entertainment Co Ltd KQ:173940	-0.501x

Annual Cash Flow Conversion Efficiency for Mgenplus Co. Ltd. (2007–2025)

The table below shows the annual cash flow conversion efficiency of Mgenplus Co. Ltd. from 2007 to 2025. View 032790 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩33.69 Billion ≈ $22.83 Million	₩-2.78 Billion ≈ $-1.89 Million	-0.083x	+38.99%
2024-12-31	₩44.12 Billion ≈ $29.90 Million	₩-5.98 Billion ≈ $-4.05 Million	-0.135x	-141.94%
2023-12-31	₩36.99 Billion ≈ $25.07 Million	₩-2.07 Billion ≈ $-1.40 Million	-0.056x	-308.67%
2022-12-31	₩46.48 Billion ≈ $31.50 Million	₩1.25 Billion ≈ $845.30K	0.027x	+119.77%
2018-12-31	₩18.38 Billion ≈ $12.46 Million	₩-2.49 Billion ≈ $-1.69 Million	-0.136x	+51.90%
2017-12-31	₩22.54 Billion ≈ $15.27 Million	₩-6.36 Billion ≈ $-4.31 Million	-0.282x	-90.52%
2016-12-31	₩11.48 Billion ≈ $7.78 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.148x	+61.17%
2015-12-31	₩8.59 Billion ≈ $5.82 Million	₩-3.28 Billion ≈ $-2.22 Million	-0.381x	-415.25%
2014-12-31	₩10.14 Billion ≈ $6.87 Million	₩1.23 Billion ≈ $831.40K	0.121x	+37.31%
2013-12-31	₩14.12 Billion ≈ $9.57 Million	₩1.24 Billion ≈ $842.96K	0.088x	-78.91%
2008-12-31	₩17.78 Billion ≈ $12.05 Million	₩7.43 Billion ≈ $5.03 Million	0.418x	+873.55%
2007-12-31	₩17.38 Billion ≈ $11.78 Million	₩745.57 Million ≈ $505.26K	0.043x	--

About Mgenplus Co. Ltd.

KQ:032790 Korea Biotechnology

Market Cap

$22.01 Million

₩32.49 Billion KRW

Market Cap Rank

#24882 Global

#1796 in Korea

Share Price

₩1265.00

Change (1 day)

+5.24%

52-Week Range

₩800.00 - ₩1631.00

All Time High

₩1631.00